BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,890,743 | -81.3% | 408,297 | -66.6% | 0.01% | -87.2% |
| Q3 2022 | $15,419,000 | +22.0% | 1,223,721 | +2.4% | 0.05% | +14.6% |
| Q2 2022 | $12,638,000 | +61.8% | 1,194,511 | -69.4% | 0.04% | -55.4% |
| Q1 2020 | $7,811,000 | +14364.8% | 3,905,676 | +35114.8% | 0.09% | – |
| Q4 2017 | $54,000 | -80.9% | 11,091 | -79.4% | 0.00% | -100.0% |
| Q3 2017 | $282,000 | -78.3% | 53,796 | -38.2% | 0.00% | -87.5% |
| Q2 2015 | $1,301,000 | – | 87,111 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |